FDA Approves Second OTC Naloxone Spray, ReVive, for Suspected Opioid Overdose

THURSDAY, Aug. 3, 2023 -- The U.S. Food and Drug Administration has approved RiVive, an over-the-counter (OTC) naloxone hydrochloride nasal spray for emergency treatment of known or suspected opioid overdose.
"We know naloxone is a powerful tool to...